Terms: = Breast cancer AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL AND Prognosis
26 results:
1. circRARS synergises with IGF2BP3 to regulate RNA methylation recognition to promote tumour progression in renal cell carcinoma.
Liu Y; Chen K; Shou Y; Li S; Wang J; Zhang Q; Huang Z; Xu J; Li M; Liu D; Liang H; Yang H; Zhang X
Clin Transl Med; 2023 Dec; 13(12):e1512. PubMed ID: 38073586
[TBL] [Abstract] [Full Text] [Related]
2. MicroRNA-143-5p Suppresses ER-Positive breast cancer Development by Targeting Oncogenic hmga2.
Mansoori B; Kiani S; Mezajin AA; Zandi P; Banaie H; Rostamzadeh D; Cho WC; Duijf PHG; Mansoori B; Baradaran B
Clin Breast Cancer; 2023 Oct; 23(7):e480-e490.e3. PubMed ID: 37596147
[TBL] [Abstract] [Full Text] [Related]
3. EGFR-Targeted liposomes Combined with Ginsenoside Rh2 Inhibit Triple-Negative breast cancer Growth and Metastasis.
Gu H; Shi R; Xu C; Lv W; Hu X; Xu C; Pan Y; He X; Wu A; Li J
Bioconjug Chem; 2023 Jun; 34(6):1157-1165. PubMed ID: 37235785
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic Significance of
Saed L; Jeleń A; Mirowski M; Sałagacka-Kubiak A
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805937
[TBL] [Abstract] [Full Text] [Related]
5. DNA-Functionalized liposomes
Zhang N; Shu G; Qiao E; Xu X; Shen L; Lu C; Chen W; Fang S; Yang Y; Song J; Zhao Z; Tu J; Xu M; Chen M; Du Y; Ji J
ACS Appl Mater Interfaces; 2022 May; 14(18):20603-20615. PubMed ID: 35476429
[TBL] [Abstract] [Full Text] [Related]
6. Integrin α
Zhou B; Li M; Xu X; Yang L; Ye M; Chen Y; Peng J; Xiao L; Wang L; Huang S; Zhang L; Lin Q; Zhang Z
Mol Pharm; 2021 Jul; 18(7):2634-2646. PubMed ID: 34134485
[TBL] [Abstract] [Full Text] [Related]
7. hmga2 promotes breast cancer metastasis by modulating Hippo-YAP signaling pathway.
Xu J; Fang X; Long L; Wang S; Qian S; Lyu J
Cancer Biol Ther; 2021 Jan; 22(1):5-11. PubMed ID: 33307962
[TBL] [Abstract] [Full Text] [Related]
8. Long Noncoding RNA LINC02163 Accelerates Malignant Tumor Behaviors in breast cancer by Regulating the MicroRNA-511-3p/hmga2 Axis.
Qin C; Jin L; Li J; Zha W; Ding H; Liu X; Zhu X
Oncol Res; 2020 Dec; 28(5):483-495. PubMed ID: 32571448
[TBL] [Abstract] [Full Text] [Related]
9. Cytoplasmic levels of high mobility group A2 determine survival prognoses in breast cancer patients.
Heilmann T; Vondung F; Borzikowsky C; Krüger S; Elessawy M; Alkatout I; Wenners A; Bauer M; Klapper W; Röcken C; Maass N; Schem C; Trauzold A
Int J Biol Markers; 2020 Jun; 35(2):20-28. PubMed ID: 32394766
[TBL] [Abstract] [Full Text] [Related]
10. Elevated high mobility group A2 expression in liver cancer predicts poor patient survival.
Zhao YC; Jiao Y; Li YQ; Fu Z; Yang ZY; He M
Rev Esp Enferm Dig; 2020 Jan; 112(1):27-33. PubMed ID: 31823639
[TBL] [Abstract] [Full Text] [Related]
11. Magnetic And pH Dual-Responsive Nanoparticles For Synergistic Drug-Resistant breast cancer Chemo/Photodynamic Therapy.
Wang D; Li X; Li X; Kang A; Sun L; Sun M; Yang F; Xu C
Int J Nanomedicine; 2019; 14():7665-7679. PubMed ID: 31571870
[TBL] [Abstract] [Full Text] [Related]
12. Enhanced cancer therapy through synergetic photodynamic/immune checkpoint blockade mediated by a liposomal conjugate comprised of porphyrin and IDO inhibitor.
Huang Z; Wei G; Zeng Z; Huang Y; Huang L; Shen Y; Sun X; Xu C; Zhao C
Theranostics; 2019; 9(19):5542-5557. PubMed ID: 31534502
[TBL] [Abstract] [Full Text] [Related]
13. The transcribed pseudogene RPSAP52 enhances the oncofetal hmga2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition.
Oliveira-Mateos C; Sánchez-Castillo A; Soler M; Obiols-Guardia A; Piñeyro D; Boque-Sastre R; Calleja-Cervantes ME; Castro de Moura M; Martínez-Cardús A; Rubio T; Pelletier J; Martínez-Iniesta M; Herrero-Martín D; Tirado OM; Gentilella A; Villanueva A; Esteller M; Farré L; Guil S
Nat Commun; 2019 Sep; 10(1):3979. PubMed ID: 31484926
[TBL] [Abstract] [Full Text] [Related]
14. Long non-coding RNA PCAT6 targets miR-204 to modulate the chemoresistance of colorectal cancer cells to 5-fluorouracil-based treatment through hmga2 signaling.
Wu H; Zou Q; He H; Liang Y; Lei M; Zhou Q; Fan D; Shen L
Cancer Med; 2019 May; 8(5):2484-2495. PubMed ID: 30938104
[TBL] [Abstract] [Full Text] [Related]
15. Gene regulation by antitumor miR-130b-5p in pancreatic ductal adenocarcinoma: the clinical significance of oncogenic EPS8.
Fukuhisa H; Seki N; Idichi T; Kurahara H; Yamada Y; Toda H; Kita Y; Kawasaki Y; Tanoue K; Mataki Y; Maemura K; Natsugoe S
J Hum Genet; 2019 Jun; 64(6):521-534. PubMed ID: 30858505
[TBL] [Abstract] [Full Text] [Related]
16. hmga2 as a functional antagonist of PARP1 inhibitors in tumor cells.
Hombach-Klonisch S; Kalantari F; Medapati MR; Natarajan S; Krishnan SN; Kumar-Kanojia A; Thanasupawat T; Begum F; Xu FY; Hatch GM; Los M; Klonisch T
Mol Oncol; 2019 Feb; 13(2):153-170. PubMed ID: 30289618
[TBL] [Abstract] [Full Text] [Related]
17. Tubular carcinomas of the breast: an epidemiologic study.
Sun JY; Zhou J; Zhang WW; Li FY; He ZY; Wu SG
Future Oncol; 2018 Dec; 14(29):3037-3047. PubMed ID: 29989443
[TBL] [Abstract] [Full Text] [Related]
18. Unusual roles of caspase-8 in triple-negative breast cancer cell line MDA-MB-231.
De Blasio A; Di Fiore R; Morreale M; Carlisi D; Drago-Ferrante R; Montalbano M; Scerri C; Tesoriere G; Vento R
Int J Oncol; 2016 Jun; 48(6):2339-48. PubMed ID: 27082853
[TBL] [Abstract] [Full Text] [Related]
19. Elevated hmga2 expression is associated with cancer aggressiveness and predicts poor outcome in breast cancer.
Wu J; Zhang S; Shan J; Hu Z; Liu X; Chen L; Ren X; Yao L; Sheng H; Li L; Ann D; Yen Y; Wang J; Wang X
Cancer Lett; 2016 Jul; 376(2):284-92. PubMed ID: 27063096
[TBL] [Abstract] [Full Text] [Related]
20. Uterine adenosarcomas are mesenchymal neoplasms.
Piscuoglio S; Burke KA; Ng CK; Papanastasiou AD; Geyer FC; Macedo GS; Martelotto LG; de Bruijn I; De Filippo MR; Schultheis AM; Ioris RA; Levine DA; Soslow RA; Rubin BP; Reis-Filho JS; Weigelt B
J Pathol; 2016 Feb; 238(3):381-8. PubMed ID: 26592504
[TBL] [Abstract] [Full Text] [Related]
[Next]
